A Study to Compare HF10 Therapy Combined with Conventional Medical Management (CMM) to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain

Overview

Información sobre este estudio

The purpose of this study is to document the safety, clinical effectiveness and cost-effectiveness of high-frequency HF10™ Therapy, delivered through the Senza system, in subjects with chronic refractory back pain (with or without leg pain) who are not considered candidates for spine surgery. This study is a multi-center, prospective, randomized study to compare the two treatment groups.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Have been diagnosed with chronic, refractory axial low back pain with a neuropathic component and are not eligible for spine surgery.
  • Have not had any surgery for back or leg pain, or any surgery resulting in back or leg pain.
  • Qualifying pain score.
  • Be on stable pain medications, as determined by the Investigator.
  • Be willing and capable of giving informed consent.
  • Be willing and able to comply with study-related requirements, procedures and visits.
  • Be capable of subjective evaluation, able to read and understand written questionnaires in the local language and are able to read, understand and sign the written inform consent

Exclusion Criteria:

  • Have a diagnosed back condition with inflammatory causes of back pain, serious spinal pathology and/or neurological disorders.
  • Have a medical condition or pain in other area(s), not intended to be treated in this study.
  • Any diagnosis or known condition that can impact reporting of study outcomes as determined by the Investigator.
  • Be benefitting within 30 days prior to enrollment from an interventional procedure to treat back and/or leg pain.
  • Have any addictions as determined by the Investigator.
  • Have an existing drug pump and/or SCS system or another active implantable device such as a pacemaker.
  • Have prior experience with neuromodulation devices.
  • Other general exclusions applicable for SCS devices.
  • Be involved in an injury claim under current litigation.
  • Have a pending or approved worker's compensation claim.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Markus Bendel, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20461420

Mayo Clinic Footer